- Home
- APLT vs FTCI Comparison
APLT vs FTCI Comparison
Compare APLT & FTCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- FTCI
- Stock Information
- Founded
- APLT 2016
- FTCI 2017
- Country
- APLT United States
- FTCI United States
- Employees
- APLT N/A
- FTCI N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- FTCI Semiconductors
- Sector
- APLT Health Care
- FTCI Technology
- Exchange
- APLT Nasdaq
- FTCI Nasdaq
- Market Cap
- APLT 37.5M
- FTCI 32.6M
- IPO Year
- APLT 2019
- FTCI 2021
- Fundamental
- Price
- APLT $0.40
- FTCI $3.37
- Analyst Decision
- APLT Buy
- FTCI Buy
- Analyst Count
- APLT 7
- FTCI 4
- Target Price
- APLT $6.10
- FTCI $5.50
- AVG Volume (30 Days)
- APLT 1.9M
- FTCI 62.7K
- Earning Date
- APLT 05-20-2025
- FTCI 05-01-2025
- Dividend Yield
- APLT N/A
- FTCI N/A
- EPS Growth
- APLT N/A
- FTCI N/A
- EPS
- APLT N/A
- FTCI N/A
- Revenue
- APLT $455,000.00
- FTCI $55,571,000.00
- Revenue This Year
- APLT $1,768.13
- FTCI $107.93
- Revenue Next Year
- APLT $361.28
- FTCI $121.09
- P/E Ratio
- APLT N/A
- FTCI N/A
- Revenue Growth
- APLT N/A
- FTCI N/A
- 52 Week Low
- APLT $0.30
- FTCI $1.76
- 52 Week High
- APLT $10.62
- FTCI $7.40
- Technical
- Relative Strength Index (RSI)
- APLT 46.92
- FTCI 59.77
- Support Level
- APLT $0.39
- FTCI $2.90
- Resistance Level
- APLT $0.44
- FTCI $3.63
- Average True Range (ATR)
- APLT 0.04
- FTCI 0.30
- MACD
- APLT 0.01
- FTCI 0.03
- Stochastic Oscillator
- APLT 45.49
- FTCI 73.47
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About FTCI FTC Solar Inc.
FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.